US Patent 12121558 Liver activation nanoemulsion and toxin excretion enhancement method
Patent 12121558 was granted and assigned to Quicksilver Scientific on October, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+43 properties)
Article (+559 characters)
US Patent 12121558 Liver activation nanoemulsion and toxin excretion enhancement method
Article
Patent abstract
An intra-oral, nanoemulsion blend is provided that enhances liver and toxin excretion performance in mammals when orally administered. A solid powder toxin binding composition also is provided that may be used to irreversibly bind the toxins reaching the bowel so that once the toxins are excreted into the bowel, they may not be reabsorbed, and are thus eliminated. A method of administering the nanoemulsion blend and the toxin binding composition to enhance toxin excretion also is described. The nanoemulsion blend is ingestible and edible.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christopher W. Shade0
Steven Tieu0
Date of Patent
October 22, 2024
0Patent Application Number
175846610
Date Filed
January 26, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12121558 Liver activation nanoemulsion and toxin excretion enhancement method
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
